AstraZeneca’s Oncology Expansion Continues: MedImmune grabs Inovio’s Cancer Vaccine
The massive expansion of AstraZeneca's pipeline continues, as its biological subsidiary, MedImmune buys Inovio Pharmaceuticals'…
11/08/2015 - 2 minutes
Medimmune
ADVERTISEMENT
Do you want to remove this advert? Become a member!
Immunocore Skyrocketed by Europe’s Largest Private Biotech Financing Ever
Immunocore Limited, just announced that it has secured a £205 million financing (€293 m) from private…
16/07/2015 - 3 minutes
Lilly Cooperates with Immunocore to Fight Skin Cancer
Eli Lilly expands its portfolio in immune-oncology therapies. This time, Immunocore's lead T cell receptor-based…
03/07/2015 - 2 minutes
Novartis Uses Antibodies from Cured Patients to Fight Viruses
Novartis just paid the bill to Humabs to use its out-licensed drug candidate in a Phase…
16/06/2015 - 2 minutes
New Collaboration for New Cancer Therapies
Medimmune, the global biologics research and development arm of Anglo-Swedish drug major AstraZeneca, has entered…
30/09/2014 - 2 minutes
